Ilias Karaiskos | Public Health | Best Researcher Award

Posted on by The Scientist

Dr. Ilias Karaiskos | Public Health | Best Researcher Award

1st Department of Internal Medicine-Infectious Diseases |  Hygeia hospital, Athens | Greece

Dr. Ilias Karaiskos is a distinguished physician and clinical researcher specializing in internal medicine and infectious diseases at the 1st Department of Internal Medicine, Hygeia General Hospital, Athens, Greece. Working under the leadership of Professor H. Giamarellou, he has contributed extensively to the management of complex infections, infection control, and antimicrobial stewardship within one of Greece’s most advanced and internationally accredited healthcare institutions. Dr. Karaiskos’s research focuses on antimicrobial pharmacokinetics, multidrug-resistant pathogens, and optimized antibiotic therapy in critically ill patients. His doctoral work on the pharmacokinetics of colistin significantly influenced global clinical practice, forming part of the International Consensus Guidelines for the Optimal Use of Polymyxins. Recognized by the Hellenic Society for Infectious Diseases with the Best PhD Award (2015), his research has shaped antibiotic dosing strategies that improve patient outcomes and reduce antimicrobial resistance. With over 80 peer-reviewed publications and an h-index of 39, Dr. Karaiskos has amassed more than 5,600 citations through collaborative studies with leading European and global research consortia, including the EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His recent works address the efficacy of novel β-lactamase inhibitors, pharmacokinetics of ceftazidime-avibactam in renal replacement therapy, and strategies for infection control in intensive care settings. Through his clinical leadership, academic collaborations, and evidence-based research, Dr. Karaiskos continues to advance the global fight against antimicrobial resistance, shaping policies and treatment guidelines that enhance the quality and safety of infectious disease management worldwide.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Karaiskos, I., … (2019). International consensus guidelines for the optimal use of the polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and others. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(1), 10–39. Citations: 949

  2. Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Karaiskos, I., … (2009). Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrobial Agents and Chemotherapy, 53(8), 3430–3436. Citations: 637

  3. Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P. R., Viale, P., Karaiskos, I., … (2017). Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): A retrospective cohort study. The Lancet Infectious Diseases, 17(7), 726–734. Citations: 545

  4. Karaiskos, I., & Giamarellou, H. (2014). Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: Current and emerging therapeutic approaches. Expert Opinion on Pharmacotherapy, 15(10), 1351–1370. Citations: 435

  5. Karaiskos, I., Lagou, S., Pontikis, K., Rapti, V., & Poulakou, G. (2019). The “old” and the “new” antibiotics for MDR Gram-negative pathogens: For whom, when, and how. Frontiers in Public Health, 7, 151. Citations: 328

Negin Maroufi | Public Health | Best Researcher Award

Posted on by The Scientist

Ms. Negin Maroufi | Public Health | Best Researcher Award

University of Otago | New Zealand

Ms. Negin Maroufi is a highly motivated Ph.D. candidate in Public Health at the University of Otago, Wellington (2023–present), specializing in the application of machine learning and multi-source surveillance data to predict seasonal influenza patterns in New Zealand to support improved prevention and health service management. She holds an M.Sc. in Computer Engineering (Software) from Islamic Azad University, Neyshabur, Iran (2018), where her thesis focused on designing approximate compressor circuits using Quantum-dot Cellular Automata, and a B.Sc. in Computer Engineering (Hardware) from Ferdowsi University of Mashhad, Iran (2013), where she developed character recognition systems via tablet digitizers. Her professional experience includes serving as Deputy of Research and Technology at Neyshabour University of Medical Sciences (2021–2023), coordinating IT infrastructure, database management, and epidemiological data analysis, and contributing to the Neyshabur Longitudinal Study on Ageing (NeLSA) from 2017–2021, where she designed databases, developed web interfaces, performed statistical analyses, and assisted in COVID-19 surveillance reporting. She has also taught English, programming, and IT courses in various institutions, demonstrating strong mentorship and teaching capabilities. Her research interests lie at the intersection of digital epidemiology, public health informatics, machine learning, and predictive modeling for infectious disease surveillance. She possesses advanced research skills in C/C#/ASP.NET programming, Python, R, STATA, SQL database design, data cleaning, machine learning, and biomedical data analysis, and holds certifications in Good Clinical Practice, biomedical research ethics, and data science. Her work has been published in reputable journals such as the Middle East Journal of Digestive Diseases and the International Journal of Epidemiology, and she has contributed to national COVID-19 epidemiology reports. Negin has received the University of Otago Doctoral Scholarship, maintained top grades throughout her academic career, and earned awards in mathematics and programming competitions. Her combined expertise, research experience, and leadership abilities position her as a promising emerging scholar in public health and digital epidemiology. 27 Citations by 27 documents, 3 Documents, h-index 1.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

  1. Aminisani, N., Azimi-Nezhad, M., Shamshirgaran, S. M., Mirhafez, S. R., Borji, A., Poustchi, H., Sezavar, S. H., Ansarin, K., Kolahi, S., Javadpor, A., Rezaei, A., Hooshmand, E., Maroufi, N., Tabaei, S., Eghtesad, S., Hyde, M., Kenny, R. A., Raina, P., Stephens, C., Malekzadeh, R. (2022). Cohort profile: The IRanian Longitudinal Study on Ageing (IRLSA): The first comprehensive study on ageing in Iran. International Journal of Epidemiology, 51(4), e177–e188. Citations: 37

  2. Maroufi, N., & Bahrepour, D. (2018). A novel three-input approximate XOR gate design based on quantum-dot cellular automata. Journal of Computational Electronics, 17(2), 866–879. Citations: 7

  3. Bahrepour, D., & Maroufi, N. (2018). A 2-bit full comparator design with a minimum quantum cost function in quantum-dot cellular automata. Information Systems & Telecommunication, 6, 197–203. Citations: 5

  4. Bahrepour, D., & Maroufi, N. (2019). A 2-bit full comparator design with minimum quantum cost function in quantum-dot cellular automata. Journal of Information Systems and Telecommunication (JIST), 4(24), 197. Citations: 3

  5. Maroufi, N., Sohrabi, M., Mehrabadi, S., Zamani, F., Ajdarkosh, H., Hatamian, S., Bahavar, A., Tameshkel, F. S., Gholami, A. (2024). Poor sleep quality and its influencing factors among Iranian patients with esophageal and gastric cancer. Middle East Journal of Digestive Diseases, 16(1), 39–46. Citations: 2